Study Reveals Myocardial Infarction May Be Caused by Bacterial Infections
By
DaveZale
Crackles when you bite it. Shows the baker did the work.
Summary
A groundbreaking study by Finnish and UK researchers reveals that myocardial infarction (heart attack) may be an infectious disease, challenging conventional medical understanding. The research found that atherosclerotic plaques in coronary artery disease can harbor asymptomatic bacterial biofilms, suggesting infections may trigger heart attacks. This discovery opens new possibilities for treatment approaches, diagnostic methods, and even vaccine development against heart disease.
Key quotes
· 4 pulledA pioneering study by researchers from Finland and the UK has demonstrated for the first time that myocardial infarction may be an infectious disease
This discovery challenges the conventional understanding of the pathogenesis of myocardial infarction
According to the recently published research, an infection may trigger myocardial infarction
atherosclerotic plaques containing cholesterol may harbour a gelatinous, asymptomatic bacterial biofilm
You might also wanna read
Personalized Vitamin D Supplementation Reduces Heart Attack Risk by 52% in Clinical Trial
A new randomized controlled trial called TARGET-D presented at the American Heart Association Scientific Sessions found that personalized vi

Clinical Trial Finds Coffee Consumption Reduces Recurrent Atrial Fibrillation Risk
A multicenter randomized clinical trial (DECAF) involving 200 patients with persistent atrial fibrillation (AF) undergoing cardioversion fou
Study Links Long-Term Melatonin Use to Increased Heart Failure and Mortality Risks
A preliminary study presented at the American Heart Association's Scientific Sessions 2025 found that long-term melatonin use (one year or l
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
